(Q44340431)

2 December 2017

title

Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost (English)

1 reference

2 December 2017

1 reference

2

Allan E Kolker

1 reference

2 December 2017

William C Stewart

1

1 reference

2 December 2017

Jeanette A Stewart

series ordinal

3

1 reference

2 December 2017

Jessica Leech

series ordinal

4

1 reference

2 December 2017

Angi L Jackson

series ordinal

5

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

American Journal of Ophthalmology

2 December 2017

published in

1 reference

2 December 2017

volume

135

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

314-320

1 reference

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901980-3

Intraocular pressure-reducing effect of PhXA41 in patients with increased eye pressure. A one-month study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901980-3

Intraocular pressure reduction with PhXA34, a new prostaglandin analogue, in patients with ocular hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901980-3

Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901980-3

Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901980-3

Differences in ocular surface irritation between timolol hemihydrate and timolol maleate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901980-3

The pharmacology of bimatoprost (Lumigan).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901980-3

Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901980-3

10.1016/S0002-9394(02)01980-3

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference